Larson Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Larson Financial Group's ADPT Position: Q3 2026 in Review
Larson Financial Group increased its Adaptive Biotechnologies (ADPT) stake by 399% in Q3 2026, buying an estimated $7.24K and bringing the position to 369 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.
Larson Financial Group first reported a position in ADPT in Q3 2025 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Larson Financial Group held 369 shares of Adaptive Biotechnologies worth $10.7K as of Q3 2026.
- Larson Financial Group bought 295 Adaptive Biotechnologies shares in Q3 2026, an estimated $7.24K.
- Adaptive Biotechnologies made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2479 holding.
- Larson Financial Group first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 5 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.